Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Hand, Foot and Mouth Disease - Overview
Hand, Foot and Mouth Disease - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Hand, Foot and Mouth Disease - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Hand, Foot and Mouth Disease - Companies Involved in Therapeutics Development
Adimmune Corp
Beijing Minhai Biotechnology Co Ltd
Changchun Bcht Biotechnology Co Ltd
Chongqing Zhifei Biological Products Co Ltd
CJ HealthCare Corp
Inmunova SA
Sentinext Therapeutics Sdn Bhd
Shanghai Zerun Biotechnology Co Ltd
Takeda Pharmaceutical Co Ltd
Hand, Foot and Mouth Disease - Drug Profiles
(coxsackievirus [serotype A16] + enterovirus [serotype 71]) (virus like particle) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
(coxsackievirus [serotype A16] + enterovirus [serotype 71]) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
B-1108 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CJ-40010 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
D-5 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
DC-07090 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
E-71 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Enterovirus [serotype EV-71/C4] vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Enterovirus [serotype EV-A71] (virus like particle, bivalent) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Enterovirus [serotype EV-A71] vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
hand, foot and mouth disease (bivalent) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
INM-008 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Monoclol Antibody for Hand, Foot and Mouth Disease - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Inhibit MAP2K1 for Hand, Foot and Mouth Disease - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
STX-100 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
TAK-021 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Hand, Foot and Mouth Disease - Dormant Projects
Hand, Foot and Mouth Disease - Product Development Milestones
Featured News & Press Releases
Mar 11, 2012: Inviragen Reports Top-Line Results From Phase I Trial Of INV21 Vaccine For Treatment Of Hand, Foot And Mouth Disease
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Figure 1: Number of Products under Development for Hand, Foot and Mouth Disease, H2 2019
Figure 2: Number of Products under Development by Companies, H2 2019
Figure 3: Number of Products under Development by Universities/Institutes, H2 2019
Figure 4: Number of Products by Targets, H2 2019
Figure 5: Number of Products by Stage and Targets, H2 2019
Figure 6: Number of Products by Mechanism of Actions, H2 2019
Figure 7: Number of Products by Stage and Mechanism of Actions, H2 2019
Figure 8: Number of Products by Stage and Routes of Administration, H2 2019
Figure 9: Number of Products by Molecule Types, H2 2019
Figure 10: Number of Products by Stage and Molecule Types, H2 2019


List of Tables


Table 1: Number of Products under Development for Hand, Foot and Mouth Disease, H2 2019
Table 2: Number of Products under Development by Companies, H2 2019
Table 3: Number of Products under Development by Universities/Institutes, H2 2019
Table 4: Products under Development by Companies, H2 2019
Table 5: Products under Development by Universities/Institutes, H2 2019
Table 6: Number of Products by Stage and Target, H2 2019
Table 7: Number of Products by Stage and Mechanism of Action, H2 2019
Table 8: Number of Products by Stage and Route of Administration, H2 2019
Table 9: Number of Products by Stage and Molecule Type, H2 2019
Table 10: Hand, Foot and Mouth Disease - Pipeline by Adimmune Corp, H2 2019
Table 11: Hand, Foot and Mouth Disease - Pipeline by Beijing Minhai Biotechnology Co Ltd, H2 2019
Table 12: Hand, Foot and Mouth Disease - Pipeline by Changchun Bcht Biotechnology Co Ltd, H2 2019
Table 13: Hand, Foot and Mouth Disease - Pipeline by Chongqing Zhifei Biological Products Co Ltd, H2 2019
Table 14: Hand, Foot and Mouth Disease - Pipeline by CJ HealthCare Corp, H2 2019
Table 15: Hand, Foot and Mouth Disease - Pipeline by Inmunova SA, H2 2019
Table 16: Hand, Foot and Mouth Disease - Pipeline by Sentinext Therapeutics Sdn Bhd, H2 2019
Table 17: Hand, Foot and Mouth Disease - Pipeline by Shanghai Zerun Biotechnology Co Ltd, H2 2019
Table 18: Hand, Foot and Mouth Disease - Pipeline by Takeda Pharmaceutical Co Ltd, H2 2019
Table 19: Hand, Foot and Mouth Disease - Dormant Projects, H2 2019